Respirerx Pharmaceuticals Inc (RSPI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2003 | 06-2003 | 03-2003 | 12-2002 | 09-2002 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,319 | N/A | -1,090 | -950 | -674 |
| Depreciation Amortization | 40 | N/A | 115 | 77 | 39 |
| Accounts receivable | 335 | N/A | 15 | 83 | -368 |
| Other Working Capital | 2,887 | N/A | -844 | -603 | -82 |
| Other Operating Activity | -12 | 0 | 120 | -12 | 429 |
| Operating Cash Flow | $-1,069 | $N/A | $-1,683 | $-1,405 | $-657 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -200 | N/A | N/A | N/A | N/A |
| PPE Investments | -8 | N/A | -3 | -3 | -1 |
| Investing Cash Flow | $-208 | $N/A | $-3 | $-3 | $-1 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 4,620 | N/A | 10 | 2 | 2 |
| Financing Cash Flow | $4,620 | $N/A | $10 | $2 | $2 |
| Beginning Cash Position | 1,125 | N/A | 1,849 | 1,849 | 1,849 |
| End Cash Position | 4,469 | N/A | 173 | 443 | 1,193 |
| Net Cash Flow | $3,344 | $N/A | $-1,677 | $-1,406 | $-656 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,069 | N/A | -1,683 | -1,405 | -657 |
| Capital Expenditure | -8 | N/A | -3 | -3 | -1 |
| Free Cash Flow | -1,076 | 0 | -1,686 | -1,408 | -658 |